Assignee
LYSANDO AG
LI·11 granted patents·9 pending applications·6 citations·filing 2012–2019
Top patents by PatentIndex Score
20 records- 0183US11136570B2Antimicrobial fusion proteins comprising an endolysin and an amphipathic peptide segmentLYSANDO AG·Filed 2019·Granted Oct 5, 2021·3 cites·8 claims
- 0274US9388400B2Composition for use in mycobacteria diagnosisLYSANDO AG·Filed 2013·Granted Jul 12, 2016·2 cites·16 claims
- 0367US11427812B2Antimicrobial agents against Staphylococcus aureusLYSANDO AG·Filed 2017·Granted Aug 30, 2022·1 cites·37 claims
- 0465US9169472B2Endolysin OBPgpLYSLYSANDO AG·Filed 2014·Granted Oct 27, 2015·0 cites·15 claims
- 0560US10137175B2Antimicrobial agentsLYSANDO AG·Filed 2014·Granted Nov 27, 2018·0 cites·22 claims
- 0658US11052137B2Antimicrobial agentsLYSANDO AG·Filed 2018·Granted Jul 6, 2021·0 cites·17 claims
- 0756US2014120074A1Antimicrobial agentsLYSANDO AG·Filed 2012·Application pending·0 cites
- 0856US2017312344A1Antimicrobial agentsLYSANDO AG·Filed 2017·Application pending·0 cites
- 0954US11958890B2Antimicrobial proteinsLYSANDO AG·Filed 2019·Granted Apr 16, 2024·0 cites·14 claims
- 1054US2016010071A1Endolysin obpgplysLYSANDO AG·Filed 2015·Application pending·0 cites
- 1152US10485854B2Method of reducing biofilmsLYSANDO AG·Filed 2016·Granted Nov 26, 2019·0 cites·12 claims
- 1246US2021198645A1Novel antimicrobial fusion proteinsLYSANDO AG·Filed 2019·Application pending·0 cites
- 1345US2015165013A1Composition for use in mycobacteria vaccinationLYSANDO AG·Filed 2013·Application pending·0 cites
- 1443US10329550B2Antimicrobial agentsLYSANDO AG·Filed 2015·Granted Jun 25, 2019·0 cites·22 claims
- 1541US2015344859A1Composition for use in mycobacteria therapyLYSANDO AG·Filed 2013·Application pending·0 cites
- 1641US2019125897A1Antimicrobial agents against salmonella bacteriaLYSANDO AG·Filed 2017·Application pending·0 cites
- 1739US2019330608A1New antimicrobial agents against enterococcus bacteriaLYSANDO AG·Filed 2017·Application pending·0 cites
- 1834US10184120B2Modified KZ144 endolysin sequenceLYSANDO AG·Filed 2014·Granted Jan 22, 2019·0 cites·20 claims
- 1932US2017106058A1Pharmaceutical composition against chronic bacterial infectionsLYSANDO AG·Filed 2015·Application pending·0 cites
- 2029US10167462B2Modified EL188 endolysin sequenceLYSANDO AG·Filed 2014·Granted Jan 1, 2019·0 cites·19 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →